Skip to main content
Livermore
Livermore
ZHEN

Fifth Third Bancorp

SEC CIK
0000035527
Latest filing
Aug 5, 2026

LGND holding history

Ligand Pharmaceuticals Inc in every 13F filed by Fifth Third Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

LGND overviewAll 13F holders of LGNDFull Q2 2026 holdings

Shares (Q2 2026)
5,921
Value
$1.87M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of LGND by Fifth Third Bancorp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20265,921$1.87M<0.1%+420+7.6%AddedHolders
Q1 20265,501$1.10M<0.1%+5,349+3,519.1%AddedHolders
Q4 2025152$28.7K<0.1%+7+4.8%AddedHolders
Q3 2025145$25.7K<0.1%+27+22.9%AddedHolders
Q2 2025118$13.4K<0.1%−7−5.6%ReducedHolders
Q1 2025125$13.1K<0.1%+38+43.7%AddedHolders
Q4 202487$9.32K<0.1%−27−23.7%ReducedHolders
Q3 2024114$11.4K<0.1%+5+4.6%AddedHolders
Q2 2024109$9.18K<0.1%+11+11.2%AddedHolders
Q1 202498$7.16K<0.1%00.0%UnchangedHolders
Q4 202398$7.00K<0.1%−55−35.9%ReducedHolders
Q3 2023153$9.17K<0.1%+25+19.5%AddedHolders
Q2 2023128$9.23K<0.1%+3+2.4%AddedHolders
Q1 2023125$9.20K<0.1%+52+71.2%AddedHolders
Q4 202273$4.88K<0.1%+32+78.0%AddedHolders
Q3 202241$4.00K<0.1%−27−39.7%ReducedHolders
Q2 202268$6.00K<0.1%+18+36.0%AddedHolders
Q1 202250$6.00K<0.1%−4,861−99.0%ReducedHolders
Q4 20214,911$759.0K<0.1%+4,824+5,544.8%AddedHolders
Q3 202187$12.0K<0.1%−148−63.0%ReducedHolders
Q2 2021235$31.0K<0.1%−56−19.2%ReducedHolders
Q1 2021291$44.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.